Research demonstrates effective cationic ring-opening polymerization of thionocarbonates, highlighting bioactive mimetics' potential.
Polysaccharide synthesis via chemical polymerization offers an efficient, facile, and cost-effective route to natural and mimetic polysaccharides with diverse biological and material properties. However, current polymerization-based approaches are largely restricted to low molecular weights (<50 kg/mol) and moderate stereoselectivity unlike their naturally derived counterparts where molecular weight is a key determinant of properties and function. Here, we report a robust strategy for constructing thiocarbonate-linked pseudo-polysaccharides via cationic ring-opening polymerization of readily accessible monosaccharide cyclic thionocarbonates. This polymerization proceeds with high reactivity and exclusive stereospecificity, affording pseudo-polysaccharides of high molecular weight across a variety of monosaccharide repeating units. Incorporation of a chain transfer agent (CTA) enables living polymerization, yielding polymers with predictable chain lengths and defined chain ends. Upon deprotection and sulfation, the resulting pseudo-polysaccharides exhibit strong fibroblast growth factor 2 (FGF2) binding and anticoagulant activity comparable to heparin, underscoring their potential as bioactive mimetics of biologically significant natural polysaccharides.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: